Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.50 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.48 |
| ▸ | ITGB3 | P05106 | 9/20 | 0.47 |
| ▸ | ITGAV | P06756 | 2/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.46 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4682778 | 0.88 | ITGB3 (0.47) | ITGB3ITGAVITGA2BACEACE2 | |
| SCHEMBL29542801 | 0.87 | ITGB3 (0.50) | CTSLITGB3ITGAVITGA2BACE | |
| SCHEMBL5085780 | 0.87 | CTSB (0.53) | CTSLITGB3ITGAVITGA2BACE | |
| SCHEMBL9828876 | 0.87 | CTSB (0.53) | CTSLITGB3ITGAVITGA2BACE | |
| SCHEMBL2928358 | 0.87 | ITGB3 (0.50) | CTSLITGB3ITGAVITGA2BACE | |
| SCHEMBL4121793 | 0.87 | ITGB3 (0.50) | CTSLITGB3ITGAVITGA2BACE | |
| SCHEMBL2185240 | 0.86 | ITGB3 (0.58) | CTSLITGB3ITGA2BACEACE2 | |
| SCHEMBL7758997 | 0.86 | ITGB3 (0.58) | CTSLITGB3ITGA2BACEACE2 | |
| SCHEMBL844471 | 0.86 | ITGB3 (0.58) | CTSLITGB3ITGA2BACEACE2 | |
| SCHEMBL5085119 | 0.86 | CTSK (0.50) | ITGB3ITGAVITGA2BGPR34ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1791837-A1 | SUBSTITUTED HYDANTOINS FOR THE TREATMENT OF CANCER | F. Hoffmann-Roche AG (CH) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006029862-A1 | SUBSTITUTED HYDANTOINS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2006-03-23 | — | — | WO | disclosed |